All Stories

  1. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems
  2. A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge
  3. A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies
  4. Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo
  5. Seroepidemiology of coxsackievirus B5 in infants and children in Jiangsu province, China
  6. Chinese vaccine products go global: vaccine development and quality control
  7. Complete Genome Sequence Analysis of Echovirus 24 Associated with Hand-Foot-and-Mouth Disease in China in 2012
  8. Hand, foot, and mouth disease in mainland China
  9. EV71 vaccine, an invaluable gift for children
  10. Strict vaccine quality control in China
  11. Quality control and evaluation of vaccines in China
  12. Regulatory science accelerates the development of biotechnology drugs and vaccines by NIFDC
  13. Re-characterization of Some Factors Influencing Aerosol Sampling in the Workplace: Results from Field Studies
  14. Identification of a novel DRB1 allele through intergenic recombination between HLA-DRB1 and HLA-DRB3∗02 in a Chinese family
  15. How to understand the efficacy measurements for enterovirus type 71 vaccine?
  16. Coxsackievirus A16
  17. Development of a sandwich ELISA for the quantification of enterovirus 71
  18. Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine
  19. Progress on the research and development of human enterovirus 71 (EV71) vaccines
  20. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines
  21. Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population
  22. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71
  23. Enhanced specific immune responses by CpG DNA in mice immunized with recombinant hepatitis B surface antigen and HB vaccine
  24. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China
  25. Preparation and Characterization of Biodegradable Microspheres Containing Hepatitis B Surface Antigen